{
    "clinical_study": {
        "@rank": "50112", 
        "arm_group": {
            "arm_group_label": "Renal Denervation", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This is a prospective, single-arm, non-randomized and open label feasibility study.  The\n      study is intended to evaluate safety and efficacy of multi-electrode radiofrequency renal\n      denervation in patients with uncontrolled hypertension."
        }, 
        "brief_title": "Multi-electrode Radiofrequency Renal Denervation System Feasibility Study", 
        "completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Uncontrolled Hypertension", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Individual is \u2265 18 and \u2264 80 years old.\n\n          -  Individual has an office systolic blood pressure of 160 mmHG or greater (\u2265 150 mmHg\n             for Type 2 diabetics) based on an average of 3 office/clinic blood pressure readings\n\n          -  Individual is adhering to a stable medication regimen including \u2265 3 anti-hypertensive\n             medications(preferred that one is a diuretic) for a minimum of two weeks prior to\n             screening.\n\n        Exclusion Criteria:\n\n          -  Individual has an estimated glomerular filtration rate (eGFR) of < 45 mL/min/1.73 m2\n\n          -  Individual has type 1 diabetes mellitus\n\n          -  Individual requires chronic oxygen support or mechanical ventilation (e.g.,\n             tracheostomy, CPAP, BiPAP) other than nocturnal respiratory support for sleep apnea.\n\n          -  Individual has primary pulmonary hypertension.\n\n          -  Individual is pregnant, nursing or planning to be pregnant."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 21, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01699529", 
            "org_study_id": "10058715DOC"
        }, 
        "intervention": {
            "arm_group_label": "Renal Denervation", 
            "description": "The Medtronic Multi-electrode Radiofrequency Renal Denervation System is comprised of a single-use, disposable catheter and a reusable generator.", 
            "intervention_name": "Medtronic Multi-electrode Radiofrequency (RF) Renal Denervation system", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "May 28, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Melbourne", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3065"
                    }, 
                    "name": "St. Vincent's Hospital Melbourne"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Melbourne", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3069"
                    }, 
                    "name": "Epworth Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Melbourne", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3004"
                    }, 
                    "name": "Alfred Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wellington", 
                        "country": "New Zealand"
                    }, 
                    "name": "Wellington Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Australia", 
                "New Zealand"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "Multi-electrode Radiofrequency Renal Denervation System Feasibility Study", 
        "overall_official": {
            "affiliation": "St Vincent's Hospital Melbourne", 
            "last_name": "Robert Whitbourn, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Australia: Department of Health and Ageing Therapeutic Goods Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Acute safety as measured by procedural complications", 
            "safety_issue": "Yes", 
            "time_frame": "1 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01699529"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Change in Office Systolic Blood Pressure", 
            "safety_issue": "No", 
            "time_frame": "Baseline to 6 months"
        }, 
        "source": "Medtronic Vascular", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medtronic Vascular", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}